focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Great tweet and very true
I still think it will be this month
https://twitter.com/tima441/status/1528380068833132544?t=HDWDMAqmxp0lWTeMXbx_CA&s=19
A few weeks ago there was lots to feel bullish about
What can we feel bullish about today. Feels like the can got kicked half way down the street. Lots of assumption and uncertainty and lots of nob delivering and reversed promises
Shareholders need and deserve a little consideration
This is my tweet - which contains extracts from the abstract along with a link
This is being presented at the AACR Meeting today in New Orleans - More positive progress
https://twitter.com/Chuggley1/status/1512690666756837377?s=20&t=c5KPZ9uQ3JSLbWOM5Lzk5g
This is an extract of an email to Ian Griffiths my question and his response.... well done working Sundays Ian
1. One of the reasons given for ovarian study delays was the challenge obtaining reagent β are you able to add any information to this i/ is it now available ii/ how much reagent is needed for the study β is it a small amount?
"Yes, unfortunately, our supplier did not meet its scheduled delivery of certain reagents as capacity was sequestered by US government for fulfilment of COVID test kits, but this has now been received and analysis is progressing."
2. We are going down the FDA approval route β as parsortix is CE marked already and has been for 10 years is there any reason why we are not applying in parallel to the UK and EU. Surely that would reduce risk and reliance on one approval and ensure eggs arenβt in one basket β unless of course Angle are extremely confident in the FDA approval
"FDA clearance is the gold standard worldwide and the US is the largest market by value and hence our primary focus. The existing CE Mark approach in Europe is βbasicβ and self-certified so does not carry the credibility that the FDA clearance does (the EU recognises this and the rules are changing this year). Nevertheless, the CE Mark provides helpful background information on Parsortix and has helped with sales to translational researchers, but it does not detail specific use of the instrument for allowing downstream analysis which is required for commercial adoption. The data provided for FDA clearance was also designed to provide the necessary package required to self-certificate in Europe for the same intended use in metastatic breast cancer, and we will make this self-certification once FDA clearance has been granted."
Great updates and feels positive
Get that. But putting all your dependency on fda doesn't really make sense. If approval was denied. Youd have to start from scratch in the UK or eu. Surely you'd derisk and have approval processes working in parallel... unless perhaps you were 100% sure of fda approval
It's an interesting point though
Whilst I'm very confident in fda approval I'm surprised all the proverbial eggs in one basket? Wouldn't you apply in multiple regions uk and Europe to reduce risk. We could potentially be commercialising in one region by now.
Maybe this demonstrates how confident angle are in fda approval
I feel dirty even coming into this cess pit again - something i try to avoid. I feel sorry for those thjat are either relegated to only post here - or need to hide behind alts in the telegram groups so they can come back here and post my feelings out of contexct
Im neither a ramper or derampoer and hold the same number of shares today as i did yesterday and as i will tomorrow
Im highly confident in where Prem are going long term and remain becuase of that and if that confidence is seen as ramping so be it - im thinking only sad traders see it this way
As to my feelings today and short term - i hop ethey show im balanced and in no way are these deramps - these are foolish terms
Im am angry at GR for laughing about assays - i normally support him and see him as doing the right thing - which i think he is - long term. Short term though non delivery of promised assays and no comment on RUS i think are harmful to sentiment which effects sp - as is evident in todays price. GR needs to deliver these things as the market (and me) expect them and only these arriving (not all in one go) will reverse sentiment an d take this share back from idiot traders
My comment about price dropping to 29 should demonstrate i am balanced and am not ramping or deramping - we are around 31 if i was deramping id be saying 20
Unlike many here im very open with my thoughts and feelings and dont carry years of baggage
Anyway - i remain positive overall and hope GR takes on board some of my thoughts - i think this month we could start seeing things improve and ill comment positively if we do
Bye - see you all in a few months